NEW YORK – Roche announced Monday the launch of its Cobas Zika test in countries that accept the CE mark.
The in vitro nucleic acid screening test detects Zika virus RNA in samples of human plasma and is intended to be used for screening blood donations with Roche's fully automated Cobas 6800/8800 systems.